LRRK2 and Alzheimer disease: Overall, our study corroborates the anti-inflammatory properties of LRRK2 kinase inhibition in preclinical models of AD- and PD-related neuroinflammation and supports the hypothesis that targeting LRRK2 activity could be protective and beneficial for brain disorders with an inflammatory component.